Paolo Caimi MD

Jan 15, 2025 | healio.com | Paolo Caimi MD |Erin Michael |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — In this video, Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, discussed research on the use of bispecific antibodies for lymphoma presented at ASH Annual Meeting and Exposition.

Jan 15, 2025 | healio.com | Paolo Caimi MD |Erin Michael |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Healio spoke with Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, about results from the inMind trial presented at ASH Annual Meeting and Exposition.

Jan 14, 2025 | healio.com | Paolo Caimi MD |Erin Michael |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Paolo Caimi, MD, spoke with Healio about the latest results from the POLARIX trial presented at ASH Annual Meeting and Exposition.

Dec 31, 2024 | healio.com | Paolo Caimi MD |Erin Michael

You've successfully added Lymphoma to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Paolo Caimi, MD, spoke with Healio about results from the REALBiTE study presented at Annual Meeting and Exposition.

Dec 19, 2024 | healio.com | Paolo Caimi MD |Erin Michael

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Paolo Caimi, MD, spoke with Healio about research updates on chimeric antigen receptor T-cell therapy presented at ASH Annual Meeting and Exposition.